Literature DB >> 23150515

Influence of lower body positive pressure on upper airway cross-sectional area in drug-resistant hypertension.

Oded Friedman1, T Douglas Bradley, Alexander G Logan.   

Abstract

We previously showed that in hypertensive patients the amount of fluid displaced from the legs overnight is directly related to the severity of obstructive sleep apnea and that the rostral fluid shift was greater in drug-resistant hypertensive patients. The findings suggested that this fluid redistribution increases upper airway collapsibility, yet more direct evidence is lacking. The present study examines the effects of graded lower body positive pressure on leg fluid volume, upper airway cross-sectional area, and neck circumference in patients with drug-resistant hypertension (n=25) and controlled hypertension (n=15). In both groups, the reduction in mean upper airway cross-sectional area and oropharyngeal junction area, assessed by acoustic pharyngometry, and the increase in neck circumference, determined by mercury strain gauge plethysmography, were related to the amount of fluid displaced from the legs (R(2)=0.41, P<0.0001; R(2)=0.42, P<0.0001; and R(2)=0.47, P<0.0001, respectively). Displacement of leg fluid volume was significantly greater in patients with drug-resistant hypertension than in controlled hypertension (P<0.0001), and as a consequence, the former experienced greater reductions in mean upper airway cross-sectional area and oropharyngeal junction area (P=0.001 and P<0.0001, respectively). The findings support the concept that in hypertensive subjects, rostral fluid displacement may participate in the pathogenesis of obstructive sleep apnea by narrowing the upper airway and making it more susceptible to collapse during sleep. The exaggerated fluid volume displacement from the legs and upper airway response to lower body positive pressure in patients with drug-resistant hypertension provide additional evidence of an important link between drug-resistant hypertension and obstructive sleep apnea.

Entities:  

Mesh:

Year:  2012        PMID: 23150515     DOI: 10.1161/HYPERTENSIONAHA.112.203547

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  15 in total

Review 1.  Effect of Antihypertensive Medications on the Severity of Obstructive Sleep Apnea: A Systematic Review and Meta-Analysis.

Authors:  Kiran Khurshid; Jonathan Yabes; Patricia M Weiss; Sushma Dharia; Lee Brown; Mark Unruh; Manisha Jhamb
Journal:  J Clin Sleep Med       Date:  2016-08-15       Impact factor: 4.062

2.  Obstructive Sleep Apnea Increases Sudden Cardiac Death in Incident Hemodialysis Patients.

Authors:  Eric S Kerns; Esther D Kim; Lucy A Meoni; Stephen M Sozio; Bernard G Jaar; Michelle M Estrella; Rulan S Parekh; Ghada Bourjeily
Journal:  Am J Nephrol       Date:  2018-08-15       Impact factor: 3.754

Review 3.  Management of Hypertension in Obstructive Sleep Apnea.

Authors:  Sofia F Furlan; Caio V Braz; Geraldo Lorenzi-Filho; Luciano F Drager
Journal:  Curr Cardiol Rep       Date:  2015-12       Impact factor: 2.931

4.  Night-to-night variability in obstructive sleep apnea severity: relationship to overnight rostral fluid shift.

Authors:  Laura H White; Owen D Lyons; Azadeh Yadollahi; Clodagh M Ryan; T Douglas Bradley
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

Review 5.  Pathogenesis of obstructive sleep apnoea in hypertensive patients: role of fluid retention and nocturnal rostral fluid shift.

Authors:  L H White; T D Bradley; A G Logan
Journal:  J Hum Hypertens       Date:  2014-10-23       Impact factor: 3.012

6.  Effective Apnea-Hypopnea Index ("Effective AHI"): A New Measure of Effectiveness for Positive Airway Pressure Therapy.

Authors:  Scott B Boyd; Raghu Upender; Arthur S Walters; R Lucas Goodpaster; Jeffrey J Stanley; Li Wang; Rameela Chandrasekhar
Journal:  Sleep       Date:  2016-11-01       Impact factor: 5.849

7.  Longitudinal Effect of CPAP on BP in Resistant and Nonresistant Hypertension in a Large Clinic-Based Cohort.

Authors:  Harneet K Walia; Sandra D Griffith; Nancy Foldvary-Schaefer; George Thomas; Emmanuel L Bravo; Douglas E Moul; Reena Mehra
Journal:  Chest       Date:  2016-01-08       Impact factor: 9.410

Review 8.  The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension.

Authors:  Jonathan A Marcus; Aravind Pothineni; Carolina Z Marcus; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2014-01       Impact factor: 5.369

Review 9.  Hypertension and obstructive sleep apnea.

Authors:  Anping Cai; Ling Wang; Yingling Zhou
Journal:  Hypertens Res       Date:  2016-02-18       Impact factor: 3.872

Review 10.  Obstructive sleep apnea and hypertension: an update.

Authors:  Tomas Konecny; Tomas Kara; Virend K Somers
Journal:  Hypertension       Date:  2013-12-30       Impact factor: 10.190

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.